pre-IPO PHARMA

COMPANY OVERVIEW

Civetta is a Cambridge, MA based cancer therapeutics company, founded to advance new medicines through small molecule targeting of beta-propeller domains with the goal of developing important therapeutics for cancers and other diseases.


LOCATION

  • Cambridge, MA, USA

  • THERAPEUTIC AREAS

  • Oncology

  • WEBSITE

    https://www.civettatherapeutics.com


    CAREER WEBSITE

    https://careers-civetta.icims.com/jobs/


    SOCIAL MEDIA


    INVESTORS

    deerfield-management


    PRESS RELEASES


    May 17, 2022

    Civetta Therapeutics Appoints Jesse Smith, Ph.D. as CSO and Susan Ashwell, Ph.D. as SVP of Chemistry


    Sep 2, 2021

    Civetta Therapeutics Announces the Appointment of Christopher D. Roberts, Ph.D., as CEO


    Dec 4, 2019

    Civetta Therapeutics Announces $53 million Series A to Advance Lead Programs and Develop Proprietary Platform Targeting Propeller Proteins


    For More Press Releases


    Google Analytics Alternative